- Pharmaceutical Products
- Products By Brand Name
- Products By Dosage Form
- Products By Generic Name
- Products By Therapeutic Class
Find a product
Find Generic
Imeg
Imeglimin Hydrochloride
Description:
Imeg® is a preparation of Imeglimin Hydrochloride. Imeglimin is the first in a new tetrahydrotriazine containing class of oral antidiabetic agents referred to as 'glimins'. The glimins are a novel class of glucose-lowering agents that target multiple components of diabetes.
Imeg® is a preparation of Imeglimin Hydrochloride. Imeglimin is the first in a new tetrahydrotriazine containing class of oral antidiabetic agents referred to as 'glimins'. The glimins are a novel class of glucose-lowering agents that target multiple components of diabetes.
Indications:
Imeg® is used for the treatment of Type 2 Diabetes Mellitus as a monotherapy or add-on therapy adjunct to diet and exercise.
Imeg® is used for the treatment of Type 2 Diabetes Mellitus as a monotherapy or add-on therapy adjunct to diet and exercise.
Mode of Action:
Imeglimin's mechanism of action involves dual effects:
(a) amplification of glucose-stimulated insulin secretion (GSIS) and preservation of ?-cell mass; and
(b) enhanced insulin action, including the potential for inhibition of hepatic glucose output and improvement in insulin signaling in both liver and skeletal muscle.
Imeglimin's mechanism of action involves dual effects:
(a) amplification of glucose-stimulated insulin secretion (GSIS) and preservation of ?-cell mass; and
(b) enhanced insulin action, including the potential for inhibition of hepatic glucose output and improvement in insulin signaling in both liver and skeletal muscle.
Different Dosages from Imeg
Other Brands From Same Therapeutic Class
